| J9271 | Injection, pembrolizumab, 1 mg | 9,400 | $40 | $385.4K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,860 | $40 | $184.7K |
| J0897 | Injection, denosumab, 1 mg | 1,620 | $20 | $29.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $100 | $21K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $140 | $21K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 170 | $90 | $15.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $130 | $9.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $170 | $6.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 80 | $60 | $4.4K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 170 | $20 | $3.7K |